These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29487236)

  • 1. Role of the Antigen Capture Pathway in the Induction of a Neutralizing Antibody Response to Anthrax Protective Antigen.
    Verma A; Ngundi MM; Price GA; Takeda K; Yu J; Burns DL
    mBio; 2018 Feb; 9(1):. PubMed ID: 29487236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
    Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.
    Chi X; Li J; Liu W; Wang X; Yin K; Liu J; Zai X; Li L; Song X; Zhang J; Zhang X; Yin Y; Fu L; Xu J; Yu C; Chen W
    Clin Vaccine Immunol; 2015 May; 22(5):553-60. PubMed ID: 25787135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
    Dumas EK; Demiraslan H; Ingram RJ; Sparks RM; Muns E; Zamora A; Larabee J; Garman L; Ballard JD; Boons GJ; James JA; Kayabas U; Doganay M; Farris AD
    PLoS One; 2020; 15(4):e0230782. PubMed ID: 32294093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.
    de Oliveira FFM; Mamillapalli S; Gonti S; Brey RN; Li H; Schiffer J; Casadevall A; Bann JG
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31941807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine.
    McComb RC; Martchenko M
    Vaccine; 2016 Jan; 34(1):13-9. PubMed ID: 26611201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunization.
    Verma A; De Pascalis R; Mocca CP; Li X; Burns DL
    mBio; 2024 Mar; 15(3):e0003724. PubMed ID: 38334423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R
    Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
    J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.
    Dumas EK; Gross T; Larabee J; Pate L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Collins LC; Spooner CE; Chen H; Ballard J; James JA; Farris AD
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK; Garman L; Cuthbertson H; Charlton S; Hallis B; Engler RJM; Choudhari S; Picking WD; James JA; Farris AD
    Vaccine; 2017 Jun; 35(26):3416-3422. PubMed ID: 28504191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.
    Vitale L; Blanset D; Lowy I; O'Neill T; Goldstein J; Little SF; Andrews GP; Dorough G; Taylor RK; Keler T
    Infect Immun; 2006 Oct; 74(10):5840-7. PubMed ID: 16988263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
    Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
    Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of the anthrax toxin by antibody-mediated stapling of its membrane-penetrating loop.
    Hoelzgen F; Zalk R; Alcalay R; Cohen-Schwartz S; Garau G; Shahar A; Mazor O; Frank GA
    Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1197-1205. PubMed ID: 34473089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-conjugated protective antigen elicits strong and durable protective antibody response against anthrax.
    Yin Y; Yu W; Li Y; Liu K; Zai X; Zhang J; Fu L; Hu T; Xu J; Chen W
    Int J Biol Macromol; 2019 Sep; 137():790-800. PubMed ID: 31279887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.
    Gorantala J; Grover S; Rahi A; Chaudhary P; Rajwanshi R; Sarin NB; Bhatnagar R
    J Biotechnol; 2014 Apr; 176():1-10. PubMed ID: 24548460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.
    Mohamadzadeh M; Durmaz E; Zadeh M; Pakanati KC; Gramarossa M; Cohran V; Klaenhammer TR
    Future Microbiol; 2010 Aug; 5(8):1289-96. PubMed ID: 20722604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activities of recombinant anthrax protective antigen co-expressed with thioredoxin in Escherichia coli.
    Ma Y; Yu YZ; Zhu YF; Xu Q; Sun ZW
    Hum Vaccin Immunother; 2013 Nov; 9(11):2371-7. PubMed ID: 23880942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.